Citi花旗银行:2024年GLP-1受体激动剂对肥胖症及其他病症的影响研究报告(英文版).pdf |
下载文档 |
资源简介
GLP-1 ‘wonder-drugs’ have crashed into the collective consciousness in recent months. Claims about easy weight loss have clogged our social media feeds. A tribe of followers has emerged. A hype cycle has developed. What’s the substance behind the hype around these drugs--which have in fact been around for several years? And what impact could they have on the global battle against obesity and beyond, in places you might not have thought about yet? In this Citi GPS report we’ll look at some of
本文档仅能预览20页



